Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer.
about
Transcriptional Targeting in Cancer Gene TherapyThe PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway.In situ gene therapy for prostate cancer: immunomodulatory approaches.Hypoxia-inducible regulation of a prodrug-activating enzyme for tumor-specific gene therapy.Molecular-genetic imaging of cancer.Gene Therapies for Cancer: Strategies, Challenges and Successes.Targeted polymeric nanoparticles for cancer gene therapy.Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer.Viral-based gene delivery and regulated gene expression for targeted cancer therapy.In vivo characterization of a prostate-specific antigen promoter-based suicide gene therapy for the treatment of benign prostatic hyperplasia.Comparison of prostate-specific promoters and the use of PSP-driven virotherapy for prostate cancer.Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector context.MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma.Regression of prostate cancer xenografts by a lentiviral vector specifically expressing diphtheria toxin A.Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter.Relative activity and specificity of promoters from prostate-expressed genes.Identification of diphtheria toxin via screening as a potent cell cycle and p53-independent cytotoxin for human prostate cancer therapeutics.Expression and functional analysis of voltage-activated Na+ channels in human prostate cancer cell lines and their contribution to invasion in vitro.Allelic variability in PSA & AR genes: a novel biomarker on the horizon for carcinoma prostate.Development of gene therapy for prostate cancer using a novel promoter of prostate-specific antigen.Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer.Expression of herpes simplex virus-thymidine kinase gene controlled by a promoter region of the midkine gene confers selective cytotoxicity to ganciclovir in human carcinoma cells.The role of herpes simplex virus thymidine kinase in the treatment of solid tumours.Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors.Expression of Drosophila Ca2+ permeable transient receptor potential-like channel protein in a prostate cancer cell line decreases cell survival.
P2860
Q24791038-BD4780D8-3E02-4BD3-BC7E-DD3A5769824AQ33599964-8F492706-012B-48C0-9ABC-7BA41A7D6677Q34452001-DC4F9E48-8E1D-46C2-8F08-75C13B431A0CQ34775024-364AC245-03A6-456C-9E7E-C396556F877BQ35116121-E5C0DD78-4F14-4697-8BB2-F3FE9F389FB0Q35186312-01A19838-E294-432A-B6C7-F6C4D77FFC41Q36416427-4AA5A22C-FD41-49AD-9412-642E88118F93Q36862380-0CD4A548-3C9F-4322-93CC-2B1561D9B4E2Q37641366-18B2130E-C723-46E6-8BAE-3A6E3EF35A90Q38520136-2B5B1CB3-E05C-42A6-B1FD-5DB47A107596Q39181862-69721B3E-851F-43C5-9F1F-EF493D5F4458Q40272344-64DC7387-2A4A-484B-8DD2-CA600A11F2FEQ40561045-8B16D2D3-7F8E-411B-8264-C340D7BB38F7Q40632767-8B07C399-ED54-4DFE-BE49-D2D5272C5B51Q40861646-AB5CE059-FA1E-4679-8DB9-E42E18FDFD44Q41051408-F05D8388-9AC6-4515-BAAD-A4224EB8E710Q41060593-05521CBA-5D32-42E5-8DC8-C4067969ED6FQ41119626-766522D2-69B2-42E8-9407-B7603E60D4C4Q41128172-64ACADEC-8E77-4699-AE9F-7128F97A8F66Q41409603-DA1CB059-EFEC-4E57-9082-D5C913FC6020Q41687354-BF6AFA56-28C6-4940-9886-889A87AF3AA7Q43553564-02F23518-7C78-418F-A87C-BEFD59F7F817Q44113154-0FF1D965-79FF-4F34-B416-81363F0C68FFQ44420566-76635FE6-C60B-4443-9C3C-C6068C180CE2Q45880080-CDA21906-6B25-4628-AF26-A9375E219226Q52609401-628646BB-F9FF-4FC7-8737-8818931EA9B0
P2860
Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Prostate tissue specificity of ...... patient with prostate cancer.
@en
type
label
Prostate tissue specificity of ...... patient with prostate cancer.
@en
prefLabel
Prostate tissue specificity of ...... patient with prostate cancer.
@en
P2093
P1433
P1476
Prostate tissue specificity of ...... patient with prostate cancer.
@en
P2093
Belldegrun AS
Dardashti K
Dekernion JB
Sokoloff M
P304
P356
10.1089/HUM.1995.6.11-1417
P577
1995-11-01T00:00:00Z